Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progesterone Receptor Negative”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05962372
What this trial is testing

Culturally Adapted Dietary Clinical Trial in PR

Who this might be right for
Diabetes Mellitus, Type 2ObesityHypertension+4 more
Harvard School of Public Health (HSPH) 250
Early research (Phase 1)Study completedNCT01435915
What this trial is testing

Ropinirole PR Pharmacokinetics Study Among Chinese Healthy Subjects

Who this might be right for
Parkinson Disease
GlaxoSmithKline 24
Testing effectiveness (Phase 2)Study completedNCT00483223
What this trial is testing

Platinum for Triple-Negative Metastatic Breast Cancer and Evaluation of p63/p73 as a Biomarker of Response

Who this might be right for
Breast Cancer
Massachusetts General Hospital 86
Early research (Phase 1)Study completedNCT00482027
What this trial is testing

Safety and Immunogenicity Study of tgAAC09, a Gag-PR-RT AAV HIV Vaccine

Who this might be right for
HIV Infection
International AIDS Vaccine Initiative 80
Testing effectiveness (Phase 2)Study completedNCT03213041
What this trial is testing

Pembrolizumab and Carboplatin in Treating Patients With Circulating Tumor Cells Positive Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor NegativeEstrogen Receptor PositiveHER2/Neu Negative+4 more
Northwestern University 12
Large-scale testing (Phase 3)UnknownNCT05985187
What this trial is testing

Clinical Study to Evaluate the Efficacy and Safety of TQB2440 Injection/Perjeta® Combined With Trastuzumab and Docetaxel in the Treatment of Patients With Early or Locally Advanced Breast Cancer.

Who this might be right for
HER2-positive Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 412
Testing effectiveness (Phase 2)Study completedNCT02418481
What this trial is testing

Safety and Efficiency of γδ T Cell Against Breast Cancer(Her-, er-, and pr-)

Who this might be right for
Breast Cancer
Fuda Cancer Hospital, Guangzhou 40
Testing effectiveness (Phase 2)Study completedNCT01147484
What this trial is testing

Foretinib in Patients With Recurrent/Metastatic Breast Cancer

Who this might be right for
Recurrent Breast Cancer
NCIC Clinical Trials Group 47
Early research (Phase 1)UnknownNCT02817932
What this trial is testing

Pharmacokinetics and Safety of Ranolazine PR in Healthy Korean and Caucasian Male Subjects

Who this might be right for
Healthy Male Individuals
A.Menarini Asia-Pacific Holdings Pte Ltd 120
Testing effectiveness (Phase 2)Study completedNCT03691493
What this trial is testing

Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Estrogen Receptor PositiveHER2/Neu Negative+4 more
Emory University 36
Post-approval studies (Phase 4)Ended earlyNCT05293106
What this trial is testing

Assessing the Hemostatic Efficacy of Pathogen Reduced Platelets in Children Undergoing Cardiopulmonary Bypass Surgery: A Pilot Clinical Trial

Who this might be right for
Cardiopulmonary Bypass Surgery
Weill Medical College of Cornell University 9
Testing effectiveness (Phase 2)Study completedNCT02005887
What this trial is testing

TRial on the Endocrine Activity of Neoadjuvant Degarelix

Who this might be right for
Breast Cancer Invasive Nos
ETOP IBCSG Partners Foundation 51
Testing effectiveness (Phase 2)Study completedNCT01677455
What this trial is testing

An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast Cancer

Who this might be right for
Breast CancerHER-2 Positive Breast CancerTriple Negative Breast Cancer+1 more
Synta Pharmaceuticals Corp. 51
Testing effectiveness (Phase 2)Study completedNCT03054363
What this trial is testing

Tucatinib, Palbociclib and Letrozole in Metastatic Hormone Receptor Positive and HER2-positive Breast Cancer

Who this might be right for
Breast Cancer
University of Colorado, Denver 42
Early research (Phase 1)Study completedNCT01791478
What this trial is testing

BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor-positive Breast CancerHER2-negative Breast CancerInvasive Ductal Breast Carcinoma+3 more
Vanderbilt-Ingram Cancer Center 46
Large-scale testing (Phase 3)Study completedNCT01438567
What this trial is testing

Demonstrate Improvement in Symptoms of Constipation in Subjects That Require Around-the-clock Opioid Pain Killer Therapy

Who this might be right for
PainConstipation
Mundipharma Research GmbH & Co KG 270
Post-approval studies (Phase 4)UnknownNCT03513601
What this trial is testing

Treatment of Elderly Patients With Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma
Mingzhi Zhang 20
Testing effectiveness (Phase 2)Study completedNCT05042297
What this trial is testing

Combined Ring (APR) Fixation Vs Posterior Ring Fixation in Tile B2 and C1 Pelvic Ring Injuries

Who this might be right for
Evaluation of PR Fixation in Tile B2 and C1 Injuries
Ain Shams University 40
Testing effectiveness (Phase 2)Study completedNCT00232505
What this trial is testing

Cetuximab + / - Carboplatin for Estrogen Receptor-Negative, Progesterone Receptor-Negative Metastatic Breast Cancer

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center 112
Testing effectiveness (Phase 2)Study completedNCT00923156
What this trial is testing

Effects of Aliskiren, Ramipril, and the Combination on Levels of Angiotensin II in Patients With Decompensated Systolic Heart Failure

Who this might be right for
Heart Failure
Novartis Pharmaceuticals 123
Next Page